• Ophthalmic Business Council

    For more than 20 years, the Foundation has facilitated the Ophthalmic Business Council (OBC) with the goal of fostering communication among leaders in the ophthalmic community. The OBC provides an ideal forum for thought leaders from the Academy, industry, government and health policy to collaborate face-to-face on ways to improve patient care.

    OBC members are invited to attend two essential symposia with unparalleled networking opportunities with Academy physician leaders and industry experts.

    To join or learn more, contact Todd Lyckberg at 415.447.0361 or tlyckberg@aao.org.

    Download brochures: AAO 2019 exhibitors and non-exhibitors

    Save the Date

    Spring 2019 Symposium
    April 11, 2019
    Washington, DC

    Held every other year, the Spring Symposium focuses on the latest first-hand from experts on FDA, Medicare and reimbursement issues. As the speed of innovation grows, this event helps you navigate the complexities of introducing new technologies and treatments to patients. Unlike the Fall Symposium, Academy leaders do not attend this meeting.

    Fall 2019 Symposium
    Sept. 5 to 6
    Westin Gaslamp Quarter Hotel
    San Diego, Calif.

    Held in conjunction with the Academy’s Board of Trustees meeting, the Fall Symposium covers the most timely and relevant issues facing ophthalmology today. In-depth presentations and open-forum discussions allow you to hear from all perspectives: physician, industry, health policy and government. The Fall Symposium is the perfect way to gain meaningful insights from key players.

    Member Benefits

    2018 - 2019 Ophthalmic Business Council 

    Crown Benefactors ($25,000)
    Alcon, Inc.
    Allergan, Inc.
    Genentech, Inc.
    Johnson & Johnson Vision
    Novartis Pharmaceuticals
    Optos, Inc.
    Regeneron Pharmaceuticals, Inc.
    Verana Health

    Benefactors ($15,000)
    Bausch + Lomb

    Patrons ($7,500)
    Boehringer Ingelheim
    Carl Zeiss Meditec, Inc.
    Horizon Pharma
    Mallinckrodt Pharmaceuticals
    Omeros Corporation
    Sun Ophthalmics

    Subscribers ($5,000)
    Aerie Pharmaceuticals, Inc.
    Akorn, Inc.
    Bio-Tissue, Inc.
    Clearside Biomedical, Inc.
    Glaukos Corporation
    Notal Vision, Inc.
    Santen, Inc.
    Spark Therapeutics, Inc.

    Members ($2,500)
    Alimera Sciences, Inc.
    Apellis Pharmaceuticals
    Aura Biosciences, Inc.
    Heidelberg Engineering
    NeoMedix Corporation
    New World Medical, Inc.
    Ocunexus Therapeutics
    ThromboGenics, Inc.
    Topcon Medical Systems, Inc.
    Zydoc Medical Transcription